ArticleJAMA network open2021

Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma.

Kanwal Raghav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.